Diabetes Prediction Using Artificial Neural Network

Diabetes is one of the most common diseases worldwide where a cure is not found for it yet. Annually it cost a lot of money to care for people with diabetes. Thus the most important issue is the prediction to be very accurate and to use a reliable method for that. One of these methods is using artificial intelligence systems and in particular is the use of Artificial Neural Networks (ANN). So in this paper, we used artificial neural networks to predict whether a person is diabetic or not. The criterion was to minimize the error function in neural network training using a neural network model. After training the ANN model, the average error function of the neural network was equal to 0.01 and the accuracy of the prediction of whether a person is diabetics or not was 87.3

An Optimized Type-2 Self-Organizing Fuzzy Logic Controller Applied in Anesthesia for Propofol Dosing to Regulate BIS

During general anesthesia, anesthesiologists who provide anesthetic dosage traditionally play a fundamental role to regulate Bispectral Index (BIS). However, in this paper, an optimized type-2 Self-Organizing Fuzzy Logic Controller (SOFLC) is designed for Target Controlled Infusion (TCI) pump related to propofol dosing guided by BIS, to realize automatic control of general anesthesia. The type-2 SOFLC combines a type-2 fuzzy logic controller with a self-organizing (SO) mechanism to facilitate online training while able to contend with operational uncertainties. A novel data driven Surrogate Model (SM) and Genetic Programming (GP) based strategy is introduced for optimizing the type-2 SOFLC parameters offline to handle inter-patient variability. A pharmacological model is built for simulation in which different optimization strategies are tested and compared. Simulation results are presented to demonstrate the applicability of our approach and show that the proposed optimization strategy can achieve better control performance in terms of steady state error and robustness

Advanced intelligent control and optimization for cardiac pacemaker systems

Since cardiovascular diseases are major causes of morbidity and mortality in the developed countries and the number one cause of death in the United States, their accurate diagnosis and effective treatment via advanced cardiac pacemaker systems have become very important. Intelligent control and optimization of the pacemakers are significant research subjects. Serious but infrequently occurring arrhythmias are difficult to diagnose. The use of electrocardiogram (ECG) waveform only cannot exactly distinguish between deadly abnormalities and temporary arrhythmias. Thus, this work develops a new method based on frequency entrainment to analyze pole-zero characteristics of the phase error between abnormal ECG and entrained Yanagihara, Noma, and Irisawa (YNI)-response. The thresholds of poles and zeros to diagnose deadly bradycardia and tachycardia are derived, respectively, for the first time. For bradycardia under different states, a fuzzy proportional-integral-derivative (FPID) controller for dual- sensor cardiac pacemaker systems is designed. It can automatically control the heart rate to accurately track a desired preset profile. Through comparing with the conventional algorithm, FPID provides a more suitable control strategy for offering better adaptation of the heart rate, in order to fulfill the patient\u27s physiological needs. This novel control method improves the robustness and performance of a pacemaker system significantly. Higher delivered energy for stimulation may cause higher energy consumption in pacemakers and accelerated battery depletion. Hence, this work designs an optimal single-pulse stimulus to treat sudden cardiac arrest, while minimizing the pulse amplitude and releasing stimulus pain. Moreover, it derives the minimum pulse amplitude for successful entrainment. The simulation results confirm that the optimal single-pulse is effective to induce rapid response of sudden cardiac arrest for heartbeat recovery, while a significant reduction in the delivered energy is achieved. The study will be helpful for not only better diagnosis and treatment of cardiovascular diseases but also improving the performance of pacemaker systems

Type-2 fuzzy sets applied to multivariable self-organizing fuzzy logic controllers for regulating anesthesia

In this paper, novel interval and general type-2 self-organizing fuzzy logic controllers (SOFLCs) are proposed for the automatic control of anesthesia during surgical procedures. The type-2 SOFLC is a hierarchical adaptive fuzzy controller able to generate and modify its rule-base in response to the controller's performance. The type-2 SOFLC uses type-2 fuzzy sets derived from real surgical data capturing patient variability in monitored physiological parameters during anesthetic sedation, which are used to define the footprint of uncertainty (FOU) of the type-2 fuzzy sets. Experimental simulations were carried out to evaluate the performance of the type-2 SOFLCs in their ability to control anesthetic delivery rates for maintaining desired physiological set points for anesthesia (muscle relaxation and blood pressure) under signal and patient noise. Results show that the type-2 SOFLCs can perform well and outperform previous type-1 SOFLC and comparative approaches for anesthesia control producing lower performance errors while using better defined rules in regulating anesthesia set points while handling the control uncertainties. The results are further supported by statistical analysis which also show that zSlices general type-2 SOFLCs are able to outperform interval type-2 SOFLC in terms of their steady state performance

Hierarchically Clustered Adaptive Quantization CMAC and Its Learning Convergence

No abstract availabl

Artificial intelligence methodologies and their application to diabetes

In the past decade diabetes management has been transformed by the addition of continuous glucose monitoring and insulin pump data. More recently, a wide variety of functions and physiologic variables, such as heart rate, hours of sleep, number of steps walked and movement, have been available through wristbands or watches. New data, hydration, geolocation, and barometric pressure, among others, will be incorporated in the future. All these parameters, when analyzed, can be helpful for patients and doctors' decision support. Similar new scenarios have appeared in most medical fields, in such a way that in recent years, there has been an increased interest in the development and application of the methods of artificial intelligence (AI) to decision support and knowledge acquisition. Multidisciplinary research teams integrated by computer engineers and doctors are more and more frequent, mirroring the need of cooperation in this new topic. AI, as a science, can be defined as the ability to make computers do things that would require intelligence if done by humans. Increasingly, diabetes-related journals have been incorporating publications focused on AI tools applied to diabetes. In summary, diabetes management scenarios have suffered a deep transformation that forces diabetologists to incorporate skills from new areas. This recently needed knowledge includes AI tools, which have become part of the diabetes health care. The aim of this article is to explain in an easy and plane way the most used AI methodologies to promote the implication of health care providers?doctors and nurses?in this field

Closed-loop control of anesthesia : survey on actual trends, challenges and perspectives

Automation empowers self-sustainable adaptive processes and personalized services in many industries. The implementation of the integrated healthcare paradigm built on Health 4.0 is expected to transform any area in medicine due to the lightning-speed advances in control, robotics, artificial intelligence, sensors etc. The two objectives of this article, as addressed to different entities, are: i) to raise awareness throughout the anesthesiologists about the usefulness of integrating automation and data exchange in their clinical practice for providing increased attention to alarming situations, ii) to provide the actualized insights of drug-delivery research in order to create an opening horizon towards precision medicine with significantly improved human outcomes. This article presents a concise overview on the recent evolution of closed-loop anesthesia delivery control systems by means of control strategies, depth of anesthesia monitors, patient modelling, safety systems, and validation in clinical trials. For decades, anesthesia control has been in the midst of transformative changes, going from simple controllers to integrative strategies of two or more components, but not achieving yet the breakthrough of an integrated system. However, the scientific advances that happen at high speed need a modern review to identify the current technological gaps, societal implications, and implementation barriers. This article provides a good basis for control research in clinical anesthesia to endorse new challenges for intelligent systems towards individualized patient care. At this connection point of clinical and engineering frameworks through (semi-) automation, the following can be granted: patient safety, economical efficiency, and clinicians' efficacy